Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening

Importance: Implementation of newborn screening (NBS) in the United States now detects infants with late-onset Pompe disease (LOPD), a lysosomal storage disease characterized by slowly progressive muscle weakness, and detailed clinical evaluation has identified early muscle weakness. Biomarkers may...

Full description

Bibliographic Details
Main Authors: David G. Jackson, Laura E. Case, Erin Huggins, Maggie Holland, Janet Blount, Lisa Hobson Webb, Priya S. Kishnani
Format: Article
Language:English
Published: Elsevier 2023-09-01
Series:Molecular Genetics and Metabolism Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2214426923000356
_version_ 1797737363444596736
author David G. Jackson
Laura E. Case
Erin Huggins
Maggie Holland
Janet Blount
Lisa Hobson Webb
Priya S. Kishnani
author_facet David G. Jackson
Laura E. Case
Erin Huggins
Maggie Holland
Janet Blount
Lisa Hobson Webb
Priya S. Kishnani
author_sort David G. Jackson
collection DOAJ
description Importance: Implementation of newborn screening (NBS) in the United States now detects infants with late-onset Pompe disease (LOPD), a lysosomal storage disease characterized by slowly progressive muscle weakness, and detailed clinical evaluation has identified early muscle weakness. Biomarkers may be uninformative; thus, non-invasive imaging is needed to assess early LOPD muscle changes. Muscle ultrasound (US) measuring echointensity (EI) is a non-invasive measure of muscle health. Objective: In this study, we aimed to evaluate if EI can identify characteristic patterns of muscle involvement in LOPD patients identified by NBS. Design/setting: Prospective, cross-sectional, single time point study. Setting: One-center study. Participants: We examined 20 infants with NBS-identified LOPD (ages 5–20 months). All had standardized physical therapy assessments. Exposures: Creatine Kinase (CK) and Urine Hexose Tetrasaccharide (Glc4) were obtained. Muscle US of deltoid, biceps brachii, forearm flexors, thoracic paraspinals, gluteus maximus, quadriceps, tibialis anterior and medial gastrocnemius was performed. Main outcomes and measures: Mean EI was calculated for all involved muscle groups. Quantitative EI Sum Scores were calculated as total EI divided by number of muscle groups assessed. We performed a comprehensive literature review to compare our results to previous LOPD muscle ultrasound studies. Results: Six of 20 participants had elevated CK and 15 had ≥50% of the most common concerning kinematic physical findings; with normal urine Glc4 in all except one. Based upon muscle EI, the most affected muscles were quadriceps and medial gastrocnemius, with notable elevated EI in thoracic paraspinals. Biceps brachii was the most frequently affected upper extremity muscle. EI sum scores correlated moderately with increasing CK. Statistically significant positive correlation was found between posterior pelvic tilt in sitting and EI of gluteus maximus. Sonographic pattern of muscle involvement was similar to previous studies assessing older patients with LOPD. Conclusions and relevance: In this study, muscle EI was elevated most often in the quadriceps, tibialis anterior, medial gastrocnemius, thoracic paraspinals, and biceps brachii. Involved muscles generally fit the profile of physical and muscle ultrasound/MRI exam findings in LOPD patients. Muscle ultrasound is recommended for rapid, focused muscle assessment in LOPD, especially those identified via NBS. Future studies should focus on this pattern of ultrasonographic abnormality and changes over time.
first_indexed 2024-03-12T13:27:37Z
format Article
id doaj.art-8db9c3e7bb6c4b70bcd62551fc430751
institution Directory Open Access Journal
issn 2214-4269
language English
last_indexed 2024-03-12T13:27:37Z
publishDate 2023-09-01
publisher Elsevier
record_format Article
series Molecular Genetics and Metabolism Reports
spelling doaj.art-8db9c3e7bb6c4b70bcd62551fc4307512023-08-25T04:24:14ZengElsevierMolecular Genetics and Metabolism Reports2214-42692023-09-0136100989Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screeningDavid G. Jackson0Laura E. Case1Erin Huggins2Maggie Holland3Janet Blount4Lisa Hobson Webb5Priya S. Kishnani6Division of Medical Genetics, Duke University Medical Center, Durham, NC, USADoctor of Physical Therapy Division, Duke University Medical Center, Durham, NC, USADivision of Medical Genetics, Duke University Medical Center, Durham, NC, USADoctor of Physical Therapy Division, Duke University Medical Center, Durham, NC, USADivision of Medical Genetics, Duke University Medical Center, Durham, NC, USADepartment of Neurology, Duke University Medical Center, Durham, NC, USADivision of Medical Genetics, Duke University Medical Center, Durham, NC, USA; Corresponding author at: Department of Pediatrics, Duke University Medical Center, Box 103856, 905 South LaSalle Street (GSRB1), Durham, NC 27710, USA.Importance: Implementation of newborn screening (NBS) in the United States now detects infants with late-onset Pompe disease (LOPD), a lysosomal storage disease characterized by slowly progressive muscle weakness, and detailed clinical evaluation has identified early muscle weakness. Biomarkers may be uninformative; thus, non-invasive imaging is needed to assess early LOPD muscle changes. Muscle ultrasound (US) measuring echointensity (EI) is a non-invasive measure of muscle health. Objective: In this study, we aimed to evaluate if EI can identify characteristic patterns of muscle involvement in LOPD patients identified by NBS. Design/setting: Prospective, cross-sectional, single time point study. Setting: One-center study. Participants: We examined 20 infants with NBS-identified LOPD (ages 5–20 months). All had standardized physical therapy assessments. Exposures: Creatine Kinase (CK) and Urine Hexose Tetrasaccharide (Glc4) were obtained. Muscle US of deltoid, biceps brachii, forearm flexors, thoracic paraspinals, gluteus maximus, quadriceps, tibialis anterior and medial gastrocnemius was performed. Main outcomes and measures: Mean EI was calculated for all involved muscle groups. Quantitative EI Sum Scores were calculated as total EI divided by number of muscle groups assessed. We performed a comprehensive literature review to compare our results to previous LOPD muscle ultrasound studies. Results: Six of 20 participants had elevated CK and 15 had ≥50% of the most common concerning kinematic physical findings; with normal urine Glc4 in all except one. Based upon muscle EI, the most affected muscles were quadriceps and medial gastrocnemius, with notable elevated EI in thoracic paraspinals. Biceps brachii was the most frequently affected upper extremity muscle. EI sum scores correlated moderately with increasing CK. Statistically significant positive correlation was found between posterior pelvic tilt in sitting and EI of gluteus maximus. Sonographic pattern of muscle involvement was similar to previous studies assessing older patients with LOPD. Conclusions and relevance: In this study, muscle EI was elevated most often in the quadriceps, tibialis anterior, medial gastrocnemius, thoracic paraspinals, and biceps brachii. Involved muscles generally fit the profile of physical and muscle ultrasound/MRI exam findings in LOPD patients. Muscle ultrasound is recommended for rapid, focused muscle assessment in LOPD, especially those identified via NBS. Future studies should focus on this pattern of ultrasonographic abnormality and changes over time.http://www.sciencedirect.com/science/article/pii/S2214426923000356Pompe diseaseUltrasoundNewborn screening
spellingShingle David G. Jackson
Laura E. Case
Erin Huggins
Maggie Holland
Janet Blount
Lisa Hobson Webb
Priya S. Kishnani
Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
Molecular Genetics and Metabolism Reports
Pompe disease
Ultrasound
Newborn screening
title Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
title_full Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
title_fullStr Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
title_full_unstemmed Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
title_short Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
title_sort muscle ultrasound in patients with late onset pompe disease identified by newborn screening
topic Pompe disease
Ultrasound
Newborn screening
url http://www.sciencedirect.com/science/article/pii/S2214426923000356
work_keys_str_mv AT davidgjackson muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT lauraecase muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT erinhuggins muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT maggieholland muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT janetblount muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT lisahobsonwebb muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening
AT priyaskishnani muscleultrasoundinpatientswithlateonsetpompediseaseidentifiedbynewbornscreening